The importance of managing hypertension and dyslipidemia to decrease cardiovascular diseaseKOSTIS, John B.Cardiovascular drugs and therapy. 2007, Vol 21, Num 4, pp 297-309, issn 0920-3206, 13 p.Article

The association of heart failure with insulin resistance and the development of type 2 diabetesKOSTIS, John B; SANDERS, Michael.American journal of hypertension. 2005, Vol 18, Num 5, pp 731-737, issn 0895-7061, 7 p., 1Article

International medical graduates and the cardiology workforceKOSTIS, John B; AHMAD, Busharat.Journal of the American College of Cardiology. 2004, Vol 44, Num 6, pp 1172-1174, issn 0735-1097, 3 p.Article

The Treatment of patients with hypertension and ischemic Heart diseaseKOSTIS, John B; BENEDICT, Claude.Cardiovascular reviews & reports. 2003, Vol 24, Num 7, pp 366-372, issn 0197-3118, 7 p.Article

From hypertension to heart failure: Update on the management of systolic and diastolic dysfunctionKOSTIS, John B.American journal of hypertension. 2003, Vol 16, Num 9, pp 18S-22S, issn 0895-7061, 2Article

Lifestyle management of erectile dysfunction : The role of cardiovascular and concomitant risk factorsROSEN, Raymond C; FRIEDMAN, Michael; KOSTIS, John B et al.The American journal of cardiology. 2005, Vol 96, Num 12B, pp 76M-79M, issn 0002-9149Conference Paper

Erectile dysfunction : Pathophysiologic mechanisms pointing to underlying cardiovascular diseaseGANZ, Peter.The American journal of cardiology. 2005, Vol 96, Num 12B, pp 8M-12M, issn 0002-9149Conference Paper

Hemodynamic and exercise effects of phosphodiesterase 5 inhibitorsJACKSON, Graham.The American journal of cardiology. 2005, Vol 96, Num 12B, pp 32M-36M, issn 0002-9149Conference Paper

Sexual dysfunction and cardiac riskKOSTIS, John B; ROSEN, Raymond C.The American journal of cardiology. 2005, Vol 96, Num 12B, issn 0002-9149, 99 p.Conference Proceedings

Atrial Fibrillation and Isolated Systolic Hypertension : The Systolic Hypertension in the Elderly Program and Systolic Hypertension in the Elderly Program-Extension StudyVAGAONESCU, Tudor D; WILSON, Alan C; KOSTIS, John B et al.Hypertension (Dallas, Tex. 1979). 2008, Vol 51, Num 6, pp 1552-1556, issn 0194-911X, 5 p.Article

Relation of endothelial cell function to erectile dysfunction : Implications for treatmentGUAY, André T.The American journal of cardiology. 2005, Vol 96, Num 12B, pp 52M-56M, issn 0002-9149Conference Paper

Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors : Focus on «-blocker interactionsKLONER, Robert A.The American journal of cardiology. 2005, Vol 96, Num 12B, pp 42M-46M, issn 0002-9149Conference Paper

Endothelial and erectile dysfunction, diabetes mellitus, and the metabolic syndrome : Common pathways and treatments?FONSECA, Vivian; JAWA, Ali.The American journal of cardiology. 2005, Vol 96, Num 12B, pp 13M-18M, issn 0002-9149Conference Paper

Prevention and management of cardiovascular disease and erectile dysfunction : Toward a common patient-centered, care modelHATZICHRISTOU, Dimitrios; TSIMTSIOU, Zoi.The American journal of cardiology. 2005, Vol 96, Num 12B, pp 80M-84M, issn 0002-9149Conference Paper

Cardiac safety in clinical trials of phosphodiesterase 5 inhibitorsCARSON, Culley C.The American journal of cardiology. 2005, Vol 96, Num 12B, pp 37M-41M, issn 0002-9149Conference Paper

Erectile dysfunction therapy in special populations and applications : Coronary artery diseaseDEBUSK, Robert F.The American journal of cardiology. 2005, Vol 96, Num 12B, pp 62M-66M, issn 0002-9149Conference Paper

Emergency department considerations regarding erectile dysfunctionHOLLANDER, Judd E.The American journal of cardiology. 2005, Vol 96, Num 12B, pp 73M-75M, issn 0002-9149Conference Paper

Overview of phosphodiesterase 5 inhibition in erectile dysfunctionROSEN, Raymond C; KOSTIS, John B.The American journal of cardiology. 2003, Vol 92, Num 9A, pp 9M-18M, issn 0002-9149Conference Paper

Heart disease risk factors predict erectile dysfunction 25 years kater (The Rancho Bernardo study)BARRETT-CONNOR, Elizabeth.The American journal of cardiology. 2005, Vol 96, Num 12B, pp 3M-7M, issn 0002-9149Conference Paper

Phosphodiesterase 5 mechanisms and therapeutic applicationsBUMETT, Arthur L.The American journal of cardiology. 2005, Vol 96, Num 12B, pp 29M-31M, issn 0002-9149Conference Paper

Sexual activity and cardiac riskCHEITLIN, Melvin D.The American journal of cardiology. 2005, Vol 96, Num 12B, pp 24M-28M, issn 0002-9149Conference Paper

Sexual dysfunction and cardiovascular disease : Integrative concepts and strategiesBILLUPS, Kevin L.The American journal of cardiology. 2005, Vol 96, Num 12B, pp 57M-61M, issn 0002-9149Conference Paper

Meta-Analysis of Statin Effects in Women Versus MenKOSTIS, William J; CHENG, Jerry Q; DOBRZYNSKI, Jeanne M et al.Journal of the American College of Cardiology. 2012, Vol 59, Num 6, pp 572-582, issn 0735-1097, 11 p.Article

Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction (from the AFFIRM study)FREUDENBERGER, Ronald S; WILSON, Alan C; KOSTIS, John B et al.The American journal of cardiology. 2007, Vol 100, Num 2, pp 247-252, issn 0002-9149, 6 p.Article

Phosphodiesterase 5 inhibition in chronic heart failure and pulmonary hypertensionPATEL, Milan D; KATZ, Stuart D.The American journal of cardiology. 2005, Vol 96, Num 12B, pp 47M-51M, issn 0002-9149Conference Paper